Category: <span>nintedanib</span>

Category: nintedanib

chemotherapy clinical trial, chemotherapy for mesothelioma, extending mesothelioma survival, Mesothelioma News, Mesothelioma treatment, nintedanib

Mesothelioma Trial for Nintedanib Shows Positive Results

 

Researchers have reported more promising results from an international, multicenter phase II clinical trial of the drug nintedanib, moving it another step closer to standard-of-care treatment for pleural mesothelioma. Nintedanib is a small-molecule enzyme inhibitor being studied as a way to increase the effectiveness of chemotherapy on mesothelioma and certain types of lung cancer. Researchers…

The post Mesothelioma Trial for Nintedanib Shows Positive Results appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

malignant pleural mesothelioma treatment, mesothelioma cancer, mesothelioma chemotherapy, mesothelioma clinical trial, Mesothelioma News, Mesothelioma treatment, nintedanib, Ofev, rama balaraman

Researchers Test Nintedanib in Mesothelioma Clinical Trial

 

Medical oncologist Dr. Rama Balaraman isn’t expecting any miracles from the pleural mesothelioma clinical trial involving nintedanib, the small-molecule enzyme inhibitor. She is expecting progress. Balaraman, at Florida Cancer Affiliates in Ocala, is participating in an international, multicenter trial that will expand the use of nintedanib within the U.S., giving patients another weapon in this…

The post Researchers Test Nintedanib in Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.